Adage Capital Partners Gp, L.L.C. Mirum Pharmaceuticals, Inc. Transaction History
Adage Capital Partners Gp, L.L.C.
- $54.9 Billion
- Q4 2024
A detailed history of Adage Capital Partners Gp, L.L.C. transactions in Mirum Pharmaceuticals, Inc. stock. As of the latest transaction made, Adage Capital Partners Gp, L.L.C. holds 150,000 shares of MIRM stock, worth $7.18 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
150,000
Previous 80,000
87.5%
Holding current value
$7.18 Million
Previous $3.12 Million
98.78%
% of portfolio
0.01%
Previous 0.01%
Shares
5 transactions
Others Institutions Holding MIRM
# of Institutions
211Shares Held
53.8MCall Options Held
2.6KPut Options Held
99.7K-
Frazier Life Sciences Management, L.P. Menlo Park, CA6.57MShares$315 Million16.29% of portfolio
-
Janus Henderson Group PLC London, X04.58MShares$219 Million0.1% of portfolio
-
Black Rock Inc. New York, NY3.24MShares$155 Million0.0% of portfolio
-
Bvf Inc San Francisco, CA2.8MShares$134 Million4.33% of portfolio
-
Eventide Asset Management, LLC Boston, MA2.61MShares$125 Million2.07% of portfolio
About Mirum Pharmaceuticals, Inc.
- Ticker MIRM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,751,700
- Market Cap $1.76B
- Description
- Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the trea...